Skip to content
Screener

Operating margin at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-11.9%-28.1pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,974.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-577.5%-597pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
25.4%+4.9pp

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed November 5, 2025. Open the filing →

Filed
Nov 5, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001689548-25-000111

FAQ

What is Praxis Precision Medicines, Inc.'s operating margin?
Praxis Precision Medicines, Inc. (PRAX) reported operating margin of -3,927.5% in Q3 2025.
How has Praxis Precision Medicines, Inc.'s operating margin changed year-over-year?
Praxis Precision Medicines, Inc.'s operating margin increased by 61.6% year-over-year, from -10,219% to -3,927.5%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Praxis Precision Medicines, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude